Dissolving Microneedle Delivery of a Prophylactic HPV Vaccine.

Dissolving Microneedle Delivery of a Prophylactic HPV Vaccine.
复制标题

DOI:
10.1021/acs.biomac.1c01345
复制
发表时间:
2022-03-14
期刊:
影响因子:
6.2
通讯作者:
Pokorski, Jonathan K.
Pokorski, Jonathan K.
中科院分区:
化学2区
文献类型:
--
作者:
Ray, Sayoni;Wirth, David M.;Ortega-Rivera, Oscar A.;Steinmetz, Nicole F.;Pokorski, Jonathan K.

文献摘要

参考文献

相似文献

由于成本高昂以及在医疗环境中进行多次接种所面临的挑战,全球绝大多数人口仍然无法获得能够预防人乳头瘤病毒 (HPV) 感染的预防性疫苗。为了改善分发和管理,我们开发了可溶解的微针,装载有热稳定的 HPV 候选疫苗,该候选疫苗由 Qβ 病毒样颗粒 (VLP) 组成,显示 HPV L2 蛋白 (Qβ-HPV) 高度保守的表位。与传统皮下注射相比,Qβ-HPV 的聚合物微针递送产生相似数量的抗 HPV16 L2 IgG 抗体,同时递送的皮内剂量要少得多。然而,发现了剂量节约效应。此外,在 HPV 假病毒检测中,免疫产生了中和抗体反应。该候选疫苗在储存几个月后被证实在室温下保持稳定,可能缓解与冷链分销相关的许多挑战。此类微针贴片疫苗易于自我给药且侵入性极小,可能有助于 HPV 疫苗的大规模分发,并提高患者的依从性。 Qβ VLP 及其交付技术是一种即插即用系统,可以作为具有广泛应用的通用平台。 Qβ VLP 可以储存用于与各种表位缀合,然后将其包装并通过非侵入性微针贴片直接递送给患者。这样的系统为疫苗的快速分发和自我管理铺平了道路。
Prophylactic vaccines capable of preventing human papillomavirus (HPV) infections are still inaccessible to a vast majority of the global population due to their high cost and challenges related to multiple administrations performed in a medical setting. In an effort to improve distribution and administration, we have developed dissolvable microneedles loaded with a thermally stable HPV vaccine candidate consisting of Qβ virus-like particles (VLPs) displaying a highly conserved epitope from the L2 protein of HPV (Qβ-HPV). Polymeric microneedle delivery of Qβ-HPV produces similar amounts of anti-HPV16 L2 IgG antibodies compared to traditional subcutaneous injection while delivering a much smaller amount of intradermal dose. However, a dose sparing effect was found. Furthermore, immunization yielded neutralizing antibody responses in a HPV pseudovirus assay. The vaccine candidate was confirmed to be stable at room temperature after storage for several months, potentially mitigating many of the challenges associated with cold-chain distribution. The ease of self-administration and minimal invasiveness of such microneedle patch vaccines may enable wide-scale distribution of the HPV vaccine and lead to higher patient compliance. The Qβ VLP and its delivery technology is a plug-and-play system that could serve as a universal platform with a broad range of applications. Qβ VLPs may be stockpiled for conjugation to a wide range of epitopes, which are then packaged and delivered directly to the patient via noninvasive microneedle patches. Such a system paves the way for rapid distribution and self-administration of vaccines.
DOI: 10.1021/ja075937f
发表时间: 2008-01-30
影响因子: 15
作者:
Prasuhn, Duane E., Jr.;Singh, Pratik;Finn, M. G.
通讯作者: Finn, M. G.
DOI: 10.15585/mmwr.mm6429a3
发表时间: 2015-07-31
期刊: MMWR. Morbidity and mortality weekly report
影响因子: --
作者:
Reagan-Steiner S;Yankey D;Jeyarajah J;Elam-Evans LD;Singleton JA;Curtis CR;MacNeil J;Markowitz LE;Stokley S
通讯作者: Stokley S
DOI: 10.3390/vaccines9010066
发表时间: 2021-01-19
期刊: Vaccines
影响因子: 7.8
作者:
Shao S;A Ortega-Rivera O;Ray S;K Pokorski J;F Steinmetz N
通讯作者: F Steinmetz N
DOI: 10.1128/cvi.00139-12
发表时间: 2012-07-01
影响因子: --
作者:
Day, Patricia M.;Pang, Yuk-Ying S.;Schiller, John T.
通讯作者: Schiller, John T.
DOI: 10.1021/mp100225y
发表时间: 2011-02-07
影响因子: 4.9
作者:
Pokorski JK;Steinmetz NF
通讯作者: Steinmetz NF